Gender-affirming hormone treatment for teenagers halted by NHS | UK News
Hormone drugs will not be prescribed by the NHS to new under-18 patients who are transitioning genders following a review into the treatment’s effectiveness. The masculinising or feminising hormones have been available on the NHS for 16 and 17-year-olds diagnosed with gender dysphoria who meet certain criteria – but new referrals have been paused from Monday. Any teenage patients in that age bracket currently receiving cross-sex hormones can continue to receive the therapy, but it must be reviewed individually with clinicians. The NHS England review found the evidence is too weak to show whether such medication is beneficial or harmful to children with gender dysphoria. It is understood the NHS is continuing to look at evidence for masculinising and feminising hormones for adults. You need javascript enabled to view this content Enable javascript to share Share Nurses win transgender case A 90-day consultation on plans to remove the treatment as a routine procedure on the NHS has now begun. The treatment will be paused throughout this period and while NHS England reviews the expected thousands …



